Dr. Timothy Charles Ball, MD, PhD

Dr. Ball practices at Incyte Pathology - Sacred Heart Medical Center Branch in Spokane, Washington.

Dr. Ball's NPI, 1073622031, was assigned on August 30, 2006. Dr. Ball holds Washington license MD60655868.

Dr. Ball's primary practice is Incyte Pathology - Sacred Heart Medical Center Branch, at 101 W 8th Ave, Spokane, WA 99204. The practice phone is (509) 474-7370.

Dr. Ball's primary practice is Incyte Pathology - Sacred Heart Medical Center Branch in Spokane, Washington. Dr. Ball is also affiliated with Prov Sacred Hrt Med Ctr & Childs Hosp. The medical group on file is TriState Health. Dmand AI also links Dr. Ball to 5 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ball practices, 9 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Ball's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Ball is board certified in cardiovascular disease by the American Board of Internal Medicine. Dr. Ball is licensed in Washington.

CMS data shows 902 Medicare services from Dr. Ball across 17 procedure codes in 2024, for 483 Medicare patients. Medicare paid $67,621 for them.

CMS counts 483 Medicare patients who saw Dr. Ball in 2024. The largest group is 75 to 84, with 194 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.45, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Ball's median patient age at 74, with 40% women.

In 2024, Dr. Ball wrote 3,486 Medicare Part D claims for 557 patients. 88% of them were for generic drugs. CMS names the drug for 3,278 of them, across 30 drugs with 11 or more claims each, at $472,177 in total drug cost. In 2023, CMS named 2,955 claims across 28 drugs.

Dr. Ball accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 32 procedures of coronary angioplasty and stenting by Dr. Ball, more than 68% of the clinicians it reports for that procedure.

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 11 papers to Dr. Ball, published from 2012 to 2016. 2016 was the busiest year, with 2. The most frequent topics are Coronary Angiography, Coronary Restenosis and Coronary Vessels. Dr. Ball has published most often in Proc (Bayl Univ Med Cent). Dr. Ball's most frequent co-authors are Jason R. Foerst, MD, Sulaiman Aziz Rathore, MD and Matthew Paul Cauchi, DO.

Dmand AI links Dr. Ball to 2 clinical trials. Conditions studied include Coronary Restenosis and Coronary Stenosis. Abbott Medical Devices sponsors the most, 2.

CMS Open Payments shows 83 general payments to Dr. Ball from 17 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 69% of the total. Tryton Medical, Inc. paid the most, $7,600.